These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 3343349)
21. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice. Guise TA; Chirgwin JM; Favarato G; Boyce BF; Mundy GR Lab Invest; 1992 Oct; 67(4):477-85. PubMed ID: 1434529 [TBL] [Abstract][Full Text] [Related]
22. Difference between 1-84 parathyroid hormone and the 1-34 fragment on renal tubular calcium transport in the dog. Puschett JB; McGowan J; Fragola J; Chen TC; Keutmann H; Rosenblatt M Miner Electrolyte Metab; 1984; 10(4):271-4. PubMed ID: 6749074 [TBL] [Abstract][Full Text] [Related]
23. Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney. Nissenson RA; Diep D; Strewler GJ J Biol Chem; 1988 Sep; 263(26):12866-71. PubMed ID: 2843501 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of renal membrane adenylate cyclase by extract of pancreatic cancer associated with humoral hypercalcemia of malignancy. Yasutomo Y; Kugai N; Nagata N; Akatsu T; Wada S; Kinoshita T; Kosano H; Takatani O Bone Miner; 1990 May; 9(2):111-20. PubMed ID: 2161691 [TBL] [Abstract][Full Text] [Related]
25. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34. Blind E; Raue F; Knappe V; Schroth J; Ziegler R Exp Clin Endocrinol; 1993; 101(3):150-5. PubMed ID: 8223983 [TBL] [Abstract][Full Text] [Related]
26. [Effect of parathyroid hormone-related protein on Na(+)-dependent phosphate transport in renal brush border membrane vesicles in rats]. Saito K; Hirano K; Kubota M; Tomino Y; Koide H Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):267-73. PubMed ID: 2062012 [TBL] [Abstract][Full Text] [Related]
27. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. Hock JM; Gera I J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281 [TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase. Rixon RH; Whitfield JF; Gagnon L; Isaacs RJ; Maclean S; Chakravarthy B; Durkin JP; Neugebauer W; Ross V; Sung W J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500 [TBL] [Abstract][Full Text] [Related]
30. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs. Stevenson RW; Parsons JA J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124 [TBL] [Abstract][Full Text] [Related]
31. Actions of synthetic parathyroid hormone-related protein(1-34) on the isolated rat kidney. Ebeling PR; Adam WR; Moseley JM; Martin TJ J Endocrinol; 1989 Jan; 120(1):45-50. PubMed ID: 2537369 [TBL] [Abstract][Full Text] [Related]
32. Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls. Henderson J; Bernier S; D'Amour P; Goltzman D Endocrinology; 1990 Sep; 127(3):1310-8. PubMed ID: 2167215 [TBL] [Abstract][Full Text] [Related]
33. PTHrP enhances the secretory response of PTH to a hypocalcemic stimulus in rat parathyroid glands. Lewin E; Almaden Y; Rodriguez M; Olgaard K Kidney Int; 2000 Jul; 58(1):71-81. PubMed ID: 10886551 [TBL] [Abstract][Full Text] [Related]
34. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Podbesek R; Edouard C; Meunier PJ; Parsons JA; Reeve J; Stevenson RW; Zanelli JM Endocrinology; 1983 Mar; 112(3):1000-6. PubMed ID: 6822201 [TBL] [Abstract][Full Text] [Related]
35. Synthetic human parathyroid hormone-related protein and rat renal electrolyte transport. Carney SL; Ray C; Ebeling PR; Martin TJ; Gillies AH Miner Electrolyte Metab; 1991; 17(1):41-5. PubMed ID: 1663207 [TBL] [Abstract][Full Text] [Related]
36. Quantitative evaluation of anticalciuretic effects of synthetic parathyroid hormonelike peptides. Scheinman SJ; Mitnick ME; Stewart AF J Bone Miner Res; 1990 Jun; 5(6):653-8. PubMed ID: 2166424 [TBL] [Abstract][Full Text] [Related]
37. Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone. Beck N; Singh H; Reed SW; Davis BB J Clin Invest; 1974 Mar; 53(3):717-25. PubMed ID: 4359938 [TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. Syed MA; Horwitz MJ; Tedesco MB; Garcia-OcaƱa A; Wisniewski SR; Stewart AF J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578 [TBL] [Abstract][Full Text] [Related]
39. Synthesis of a gene encoding parathyroid hormone-like protein-(1-141): purification and biological characterization of the expressed protein. Thorikay M; Kramer S; Reynolds FH; Sorvillo JM; Doescher L; Wu T; Morris CA; Burtis WJ; Insogna KL; Valenzuela DM Endocrinology; 1989 Jan; 124(1):111-8. PubMed ID: 2535801 [TBL] [Abstract][Full Text] [Related]
40. Comparison of the pharmacokinetics of parenteral parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in healthy young humans. Fraher LJ; Klein K; Marier R; Freeman D; Hendy GN; Goltzman D; Hodsman AB J Clin Endocrinol Metab; 1995 Jan; 80(1):60-4. PubMed ID: 7829640 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]